NRX Pharmaceuticals, Inc. Diluted Shares Outstanding (Weighted Average)
NRX Pharmaceuticals, Inc. (NRXP) reported Diluted Shares Outstanding (Weighted Average) of 8.85 million shares for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2024-05-14
- NRX Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2024-03-31 was 8.85M shares, a 33.17% increase year-over-year.
- NRX Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2023-09-30 was 81.95M shares, a 23.32% increase year-over-year.
- NRX Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2023-06-30 was 73.22M shares, a 11.39% increase year-over-year.
- NRX Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2023-03-31 was 6.65M shares, a 89.56% decline year-over-year.
- NRX Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 65.77M shares, a 40.17% increase from fiscal 2021.
- NRX Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for fiscal 2021 was 46.92M shares, a 36.90% increase from fiscal 2020.
- NRX Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for fiscal 2020 was 34.27M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|---|---|---|
| 2024-03-31 | 8.85M shares 10-Q · filed 2024-05-14 | ||||||
| 2023-09-30 | 81.95M shares 10-Q · filed 2023-11-14 | 77.58M shares derived: average of 2 quarters · filed 2023-11-14 | 74.11M shares 10-Q · filed 2023-11-14 | 57.07M shares derived: average of 4 quarters · filed 2024-05-14 | |||
| 2023-06-30 | 73.22M shares 10-Q · filed 2023-08-14 | 70.26M shares 10-Q · filed 2023-08-14 | 48.78M shares derived: average of 3 quarters · filed 2024-05-14 | 53.20M shares derived: average of 4 quarters · filed 2024-05-14 | |||
| 2023-03-31 | 6.65M shares 10-Q · filed 2024-05-14 | 67.45M shares 10-Q · filed 2023-05-15 | 36.56M shares derived: average of 2 quarters · filed 2024-05-14 | 46.52M shares derived: average of 3 quarters · filed 2024-05-14 | 51.32M shares derived: average of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | 66.47M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 66.46M shares derived: average of 2 quarters · filed 2023-11-14 | 66.22M shares derived: average of 3 quarters · filed 2023-11-14 | 65.77M shares 10-K · filed 2023-03-31 | |||
| 2022-09-30 | 66.45M shares 10-Q · filed 2023-11-14 | 66.09M shares derived: average of 2 quarters · filed 2023-11-14 | 65.53M shares 10-Q · filed 2023-11-14 | 63.41M shares derived: average of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | 65.73M shares 10-Q · filed 2023-08-14 | 64.35M shares 10-Q · filed 2023-08-14 | 62.40M shares derived: average of 3 quarters · filed 2023-08-14 | 59.73M shares derived: average of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | 63.67M shares 10-Q · filed 2023-05-15 | 60.73M shares derived: average of 2 quarters · filed 2023-05-15 | 57.74M shares derived: average of 3 quarters · filed 2023-05-15 | 53.93M shares derived: average of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | 57.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 54.77M shares derived: average of 2 quarters · filed 2023-03-31 | 50.68M shares derived: average of 3 quarters · filed 2023-03-31 | 46.92M shares 10-K · filed 2023-03-31 | |||
| 2021-09-30 | 51.74M shares 10-Q · filed 2022-11-14 | 51.05M shares 10-Q · filed 2021-11-15 | 47.12M shares derived: average of 2 quarters · filed 2022-11-14 | 43.29M shares 10-Q · filed 2022-11-14 | 43.05M shares 10-Q · filed 2021-11-15 | 41.39M shares derived: average of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | 42.49M shares 10-Q · filed 2022-08-15 | 41.73M shares 10-Q · filed 2021-08-16 | 39.14M shares 10-Q · filed 2022-08-15 | 38.71M shares 10-Q · filed 2021-08-16 | 37.95M shares derived: average of 3 quarters · filed 2022-08-15 | 36.99M shares derived: average of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | 35.66M shares 10-Q · filed 2022-05-16 | 35.67M shares derived: average of 2 quarters · filed 2022-05-16 | 35.16M shares derived: average of 3 quarters · filed 2022-08-12 | 35.53M shares derived: average of 4 quarters · filed 2022-08-12 | |||
| 2020-12-31 | 35.69M shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-03-31 | 34.91M shares derived: average of 2 quarters · filed 2022-08-12 | 35.49M shares derived: average of 3 quarters · filed 2022-08-12 | 34.27M shares 10-K · filed 2022-03-31 | |||
| 2020-09-30 | 34.14M shares 10-Q/A · filed 2022-08-12 | 35.40M shares derived: average of 2 quarters · filed 2022-08-12 | 33.80M shares 10-Q/A · filed 2022-08-12 | ||||
| 2020-06-30 | 36.66M shares 10-Q/A · filed 2022-08-12 | 33.80M shares 10-Q/A · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |